United States · FDA National Drug Code directory

Hydroxyzine Pamoate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2187_c0538532-e7e9-475c-8598-f88bc06b1779
Product NDC
71335-2187
Form
CAPSULE
Composition / generic term
Hydroxyzine Pamoate
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
19840701
Source listing expiry
20261231

Source-listed ingredients

  • HYDROXYZINE PAMOATE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 20 CAPSULE in 1 BOTTLE (71335-2187-1) · 71335-2187-1
  • 30 CAPSULE in 1 BOTTLE (71335-2187-2) · 71335-2187-2
  • 100 CAPSULE in 1 BOTTLE (71335-2187-3) · 71335-2187-3
  • 10 CAPSULE in 1 BOTTLE (71335-2187-4) · 71335-2187-4
  • 15 CAPSULE in 1 BOTTLE (71335-2187-5) · 71335-2187-5
  • 60 CAPSULE in 1 BOTTLE (71335-2187-6) · 71335-2187-6
  • 90 CAPSULE in 1 BOTTLE (71335-2187-7) · 71335-2187-7
  • 120 CAPSULE in 1 BOTTLE (71335-2187-8) · 71335-2187-8
  • 42 CAPSULE in 1 BOTTLE (71335-2187-9) · 71335-2187-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →